Use of Oral Contraceptives and The Risk Of Obesity In Women
Abstract
Oral contraception is a method that can be used to support family planning programs. However, there are some side effects that can be caused by the use of oral contraceptives, one of which is weight gain, which is a major risk factor for obesity. Obesity is known as a factor in the development of hypertension and diabetes mellitus. This research aimed to analyze the correlation between duration of use and type of oral contraception that is alleged to have a risk of obesity.
This study using an observational method with an analytic cross-sectional study design. The data was taken based on acceptors’ medical records for the period January 2018-March 2019. Data collection techniques using purposive sampling with samples that comply with the inclusion and exclusion criteria is 68 samples.
The results showed that the longer used of oral contraception, the higher the risk of obesity in oral contraception acceptors (p = 0.001; OR = 20.7; CI95% = 4.87-87.95). Using the type of combined oral contraceptives also has a higher risk of obesity in oral contraception acceptors (p = 0.011; OR = 10.2; CI95% = 1.25-82.87). The conclusion of this study that duration of use and type of oral contraception has a correlation with the risk of obesity.
References
[2]. Hariadini AL, Wijayati AI, Pramestutie HR, Illahi RK. Gambaran Kejadian Efek Samping dan Angka Kunjungan Ulang Akseptor Kontrasepsi Oral kepada Tenaga Kesehatan (Studi Pendahuluan guna Pembuatan Alat Bantu Konseling berupa Aplikasi Komputer “Sukses Ber-KB” di Apotek Kota Malang). Pharmaceutical Journal of Indonesia. 2017; 3(1): 17-23.
[3]. Badan Pusat Statistik Indonesia. Statistik Indonesia 2012. Tersedia di https://www.bps.go.id (Diakses pada 12 Agustus 2019)
[4]. Rakhi J, Sumathi M. Contraceptive Methods: Needs, Options and Utilization. The Journal of Obstetrics and Gynecology of India. 2011; 61(6): 626-634.
[5]. Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. Riset Kesehatan Dasar (Riskesdas 2013). Jakarta: Kementrian Kesehatan Republik Indonesia; 2013.
[6]. Felisa. Performance Analyzer. Tersedia di https://manajemenpk.bkkbn.go.id (Diakses pada 12 Agustus 2019).
[7]. Octaviary C, Wagiyo. Efek Penggunaan Alat Kontrasepsi Pil dan Suntik 3 Bulan terhadap Status Gizi dan Tekanan Darah pada Akseptor KB di Puskesmas Kedungmundu Semarang. Jurnal Ilmu Keperawatan Dan Kebidanan. 2015; 1(1): 1-13.
[8]. Simmon KB, Edelman AB. Hormonal Contraception and Obesity. Fertil Steril. 2016; 106 (6):1282-1288.
[9]. Ibrahim, Z. Kenaikan Berat Badan dengan Lama Pemakaian Alat Kontrasepsi Hormonal Wilayah Kerja Puskesmas Pembantu Sungai Mengkuang Tahun 2015. Journal Endurance. 2016; 1(1): 22-27.
[10]. World Health Organization. Clinical Guidelines: Contraceptive Considerations in Obese Women. Society of Family Planning. 2009; 80: 583-590.
[11]. World Health Organization. The Partership for Maternal, Newborn & Child Health. Tersedia di http://www.who.int/ (Diakses pada 16 Agustus 2019 dan 19 Agustus 2019)
[12]. Darmawati, Fitri Z. Hubungan Penggunaan Kontrasepsi Hormonal dengan Kenaikan Berat Badan pada Akseptor Kontrasepsi Hormonal di Desa Batoh Tahun 2012. Jurnal Ilmu Keperawatan. 2013; 1(1): 1-8.
[13]. Grantham JP, Henneberg M. The Estrogen Hypothesis of Obesity. Plos One. 2014; 9(6): 1-7.
[14]. Mexitalia M, Fahmi I, Susanto R, Yamauchi T. Hubungan Fungsi Tiroid dengan Energy Expenditure pada Remaja. Sari Pediatri. 2011; 12(5): 323-327.
[15]. Safitri R, Rayani T. Gambaran Kenaikan Berat Badan Ibu Akseptor Pil Oral Kombinasi di Klinik Bps “K” Desa Glanggang Kecamatan Pakisaji Kabupaten Malang. Jurnal Hesti Wira Sakti. 2016; 4(1): 51-57.
[16]. Varney. Manajemen Kebidanan. 2010; Jakarta: EGC.
[17]. Sulastri D, Elmatris, Ramadhani R. Hubungan Obesitas dengan Kejadian Hipertensi pada Masyarakat Etnik Minangkabau di Kota Padang. Majalah Kedokteran Andalas. 2012; 36(2): 188-201.
[18]. Nasution LK, Siagian A, Lubis R. Hubungan Obesitas terhadap Kejadian Diabetes Melitus Tipe 2 pada Wanita Subur di Wilayah Kerja Puskesmas Pintupadang. Jurnal Muara Sains, Teknologi, Kesehatan, dan Ilmu Kesehatan. 2018; 2(1): 240-246.
[19]. Hartanto, H. Keluarga Berencana dan Kontrasepsi. Jakarta: Pustaka Sinar Harapan; 2010.
[20]. Nur R, Rahmad A, Nurhalimah. Penggunaan Kontrasepsi dan Perubahan Berat Badan Akseptor KB. Asian Journal Of Environment, History And Heritage. 2017; 1(1): 131-140.
[21]. Safitri ME. Penggunaan Alat Kontrasepsi Hormonal terhadap Perubahan Fisik Ibu di Klinik Anita Medan. Lentera. 2015; 15(4): 53-58.
[22]. Fitriani D. Peran Estrogen dan Leptin dalam Homeostasis Energi. Jurnal Ilmu Kedokteran dan Kesehatan. 2018; 5(2): 123-131.
[23]. Andriyati D, Barus RP, Sukatendel K, Affendy M, Siregar HS, Marpaung J. Perbandingan Berat Badan pada Akseptor Kontrasepsi Hormonal Oral Kombinasi Sebelum, Sesudah 6 Bulan dan 12 Bulan Penggunaan. Majalah Kedokteran Nusantara. 2014; 47(3): 116-120.
[24]. Lizcano F, Guzman G. Estrogen Deficiency and the Origin of Obesity during Menopause. BioMed Research International. 2014: 1-11.
[25]. Patidar OD. Higher Prevalence Rate of CHD in ‘Apple Type of Obesity’ Cases as Compared to ‘Pear Type Obesity’ Cases. Indian Journal of Clinical Practice. 2013; 23(12): 791-794.
[26]. World Health Organization. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. Geneva: WHO; 2008
[27]. Nurrahmawati F, Fatmaningrum W. Hubungan Usia, Stres, dan Asupan Zat Gizi Makro dengan Kejadian Obesitas Abdominal pada Ibu Rumah Tangga di Kelurahan Sidotopo, Surabaya. Amerta Nutr. 2018: 254-264.
